|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 290.05 USD | -1.86% |
|
+0.02% | +11.28% |
| Jun. 17 | Saudi Arabia Signs Multiple Healthcare Deals, Partnerships at BIO 2025 | MT |
| Jun. 13 | Alert on Amgen documentary about bad cholesterol withdrawn | RE |
Chart calendar Amgen Inc.
9.oKAgYDRpbhbfMeRUf8keUprSK3qQBI6qF5hh1dzpZM0.4s9LUX4rB2-OQZxlGo9oJPCdRUr_fLmHYdYymZTfF6_M51NXdRkcTI1p1A~6b3bb2f7d3a78aaa7df9e84f8aeaf002
Upcoming events on Amgen Inc.
Past events on Amgen Inc.
Past dividends on Amgen Inc.
| 2025-05-15 | Quarterly 2.38 USD |
| 2025-02-13 | Quarterly 2.38 USD |
| 2024-11-17 | Quarterly 2.25 USD |
| 2024-08-15 | Quarterly 2.25 USD |
| 2024-05-15 | Quarterly 2.25 USD |
| 2024-02-14 | Quarterly 2.25 USD |
| 2023-11-15 | Quarterly 2.13 USD |
| 2023-08-16 | Quarterly 2.13 USD |
| 2023-05-16 | Quarterly 2.13 USD |
| 2023-02-13 | Quarterly 2.13 USD |
| 2022-11-15 | Quarterly 1.94 USD |
| 2022-08-16 | Quarterly 1.94 USD |
| 2022-05-15 | Quarterly 1.94 USD |
| 2022-02-13 | Quarterly 1.94 USD |
| 2021-11-14 | Quarterly 1.76 USD |
| 2021-08-15 | Quarterly 1.76 USD |
| 2021-05-13 | Quarterly 1.76 USD |
| 2021-02-10 | Quarterly 1.76 USD |
| 2020-11-12 | Quarterly 1.6 USD |
| 2020-08-13 | Quarterly 1.6 USD |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 26 323 26 247 0.29% | 28 190 28 108 0.29% | 33 424 33 188 0.71% | 35 253 | 35 887 | 36 983 |
|
EBITDA Million USD | Released Forecast Spread | 16 178 15 935 1.53% | 17 470 16 351 6.84% | 20 620 18 896 9.12% | 18 174 | 18 292 | 18 763 |
|
EBIT Million USD | Released Forecast Spread | 12 761 12 728 0.26% | 13 399 13 423 -0.18% | 15 028 14 802 1.52% | 15 552 | 15 751 | 16 270 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 7 346 7 466 -1.6% | 7 855 8 859 -11.33% | 4 609 6 690 -31.1% | 8 890 | 9 113 | 10 577 |
|
Net income Million USD | Released Forecast Spread | 6 552 6 525 0.41% | 6 717 7 401 -9.24% | 4 090 4 987 -17.99% | 6 730 | 7 526 | 8 649 |
|
EPS USD | Released Forecast Spread | 12,1 12,1 0.41% | 12,5 13,8 -9.66% | 7,56 9,13 -17.21% | 13,5 | 15,0 | 16,5 |
| Announcement Date | 31/01/23 | 06/02/24 | 04/02/25 | - |
Quarterly results
| Fiscal Period | March | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 6 903 6 948 -0.65% | 8 196 8 106 1.11% | 7 447 7 453 -0.08% | 8 388 8 348 0.47% | 8 503 8 499 0.05% | 9 086 8 869 2.44% | 8 149 8 035 1.42% | 8 861 | 8 921 | 9 296 | 8 296 | 8 961 | 8 988 | 9 348 |
|
EBITDA Million USD | Released Forecast Spread | 4 298 4 443 -3.25% | 5 040 4 568 10.32% | 4 477 4 373 2.37% | 4 915 5 301 -7.28% | 5 440 5 103 6.61% | 5 430 4 631 17.27% | 4 986 4 674 6.68% | 4 565 | 4 604 | 4 643 | 4 631 | 5 321 | 5 303 | 5 071 |
|
EBIT Million USD | Released Forecast Spread | 3 403 3 424 -0.62% | 3 660 3 689 -0.78% | 3 078 3 164 -2.71% | 3 873 3 830 1.12% | 4 044 3 884 4.13% | 4 033 3 843 4.94% | 3 599 3 318 8.47% | 3 920 | 3 997 | 3 953 | 3 425 | 3 945 | 4 003 | 4 029 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1 947 2 183 -10.81% | 852 1 517 -43.85% | -68,0 1 214 -105.6% | 794 1 630 -51.27% | 3 101 1 385 123.85% | 782 1 836 -57.41% | 1 973 1 337 47.59% | 2 317 | 2 620 | 2 621 | ||||
|
Net income Million USD | Released Forecast Spread | 1 730 1 772 -2.38% | 767 1 308 -41.36% | -113 1 127 -110.03% | 746 1 219 -38.82% | 2 830 1 348 109.99% | 627 1 243 -49.54% | 1 730 1 053 64.24% | 1 462 | 1 605 | 1 639 | 1 239 | 1 835 | 1 830 | 1 644 |
|
EPS USD | Released Forecast Spread | 3,22 3,29 -2.1% | 1,42 2,36 -39.72% | -0,21 2,71 -107.75% | 1,38 2,57 -46.26% | 5,22 2,61 100.1% | 1,16 2,49 -53.42% | 3,20 1,89 69.58% | 3,10 | 3,64 | 3,33 | 3,10 | 4,17 | 4,55 | 4,32 |
| Announcement Date | 31/10/23 | 06/02/24 | 02/05/24 | 06/08/24 | 30/10/24 | 04/02/25 | 01/05/25 | - | - | - | - | - | - | - |
| 2025-07-09 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release |
| 2025-07-15 | GLAND PHARMA LIMITED: Q1 2026 Earnings Release (Projected) |
| 2025-07-16 06:45 am | JOHNSON & JOHNSON: Q2 2025 Earnings Release |
| 2025-07-16 | NOVARTIS AG: Q2 2025 Earnings Release |
| 2025-07-16 | CAMURUS AB: Q2 2025 Earnings Release |
| 2025-07-17 | JUBILANT PHARMOVA LIMITED: Q1 2026 Earnings Release (Projected) |
| 2025-07-18 05:00 am | ORION OYJ: Q2 2025 Earnings Release |
| 2025-07-22 | LABORATORIOS FARMACEUTICOS ROVI, S.A.: Q2 2025 Earnings Release (Projected) |
| 2025-07-22 | TILRAY BRANDS, INC.: Q4 2025 Earnings Release (Projected) |
| 2025-07-22 | GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.: Q2 2025 Earnings Release (Projected) |
Past sector events for Amgen Inc.
| 2025-06-16 | MEDINCELL S.A.: Q4 2025 Earnings Release |
| 2025-06-10 04:38 am | LOTUS PHARMACEUTICAL CO., LTD.: May 2025 Sales and Revenue Release |
| 2025-06-09 04:48 am | YUNGSHIN GLOBAL HOLDING CORPORATION: May 2025 Sales and Revenue Release |
| 2025-06-08 08:01 pm | BORA PHARMACEUTICALS CO., LTD.: May 2025 Sales and Revenue Release |
| 2025-06-06 04:47 am | CALIWAY BIOPHARMACEUTICALS CO., LTD.: May 2025 Sales and Revenue Release |
| 2025-06-05 04:37 am | TTY BIOPHARM COMPANY LIMITED: May 2025 Sales and Revenue Release |
| 2025-06-03 04:35 am | ONENESS BIOTECH CO., LTD.: May 2025 Sales and Revenue Release |
| 2025-05-30 09:46 am | ASTRAZENECA PHARMA INDIA LIMITED: Q4 2025 Earnings Release |
| 2025-05-29 07:00 am | ROIVANT SCIENCES LTD.: Q4 2024 Earnings Release |
| 2025-05-29 04:31 am | ALKEM LABORATORIES LIMITED: Q4 2025 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AMGN Stock
- Calendar Amgen Inc.
Select your edition
All financial news and data tailored to specific country editions
